摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-phenyl-3-(4-methoxyphenyl)-2-methoxycarbonyl-4-nitro-1H-pyrrole | 943817-27-4

中文名称
——
中文别名
——
英文名称
5-phenyl-3-(4-methoxyphenyl)-2-methoxycarbonyl-4-nitro-1H-pyrrole
英文别名
methyl 3-(4-methoxyphenyl)-4-nitro-5-phenyl-1H-pyrrole-2-carboxylate
5-phenyl-3-(4-methoxyphenyl)-2-methoxycarbonyl-4-nitro-1H-pyrrole化学式
CAS
943817-27-4
化学式
C19H16N2O5
mdl
——
分子量
352.346
InChiKey
LDTPFRKNCCBBIY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    97.1
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
    申请人:Ikerchem, S.L.
    公开号:EP2508510A1
    公开(公告)日:2012-10-10
    The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.
    本发明涉及从羟基苯基1H-吡咯环衍生的化合物,其具有以下公式(I):以及其制备方法,包括相同成分的药物组合物以及用于治疗和/或预防由组蛋白去乙酰化酶介导的病症,如癌症、血液恶性肿瘤、自身免疫疾病、炎症性疾病、中枢神经系统(CNS)疾病如神经退行性疾病和精神障碍、心血管疾病、内分泌和代谢紊乱,通过抑制组蛋白去乙酰化酶和与所述抑制相关的生物过程的治疗用途。
  • HYDROXYPHENYL PYRROLE COMPOUNDS CONTAINING AN HYDROXAMIC ACID AS HDAC INHIBITORS AND MEDICINAL APPLICATIONS THEREOF
    申请人:Cossío Mora Fernando Pedro
    公开号:US20150038545A1
    公开(公告)日:2015-02-05
    The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.
    本发明涉及从羟基苯基1H-吡咯环衍生的化合物,其具有以下式子(I): 同时,本发明还涉及其制备方法、包含相同化合物的药物组合物以及将其用于治疗和/或预防由组蛋白去乙酰化酶介导的疾病,如癌症、血液恶性肿瘤、自身免疫疾病、炎症性疾病、中枢神经系统(CNS)疾病,如神经退行性疾病和精神障碍、心血管疾病、内分泌和代谢性疾病,通过抑制组蛋白去乙酰化酶和与所述抑制相关的生物过程的治疗用途。
  • Pyrrolic Derivatives with Histone Deacetylase Inhibitory Activity
    申请人:Cossio Mora Fernando Pedro
    公开号:US20080262073A1
    公开(公告)日:2008-10-23
    The invention describes new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases.
  • US7638550B2
    申请人:——
    公开号:US7638550B2
    公开(公告)日:2009-12-29
  • NOVEL PYRROLE DERIVATIVES WITH HISTONE DEACETYLASE INHIBITOR ACTIVITY
    申请人:UNIVERSIDAD DEL PAIS VASCO-EUSKAL HERRIKO UNIBERSITATEA
    公开号:EP1975158B9
    公开(公告)日:2012-02-29
查看更多